2019 Emerging Leader Award

Program Overview

The Mark Foundation Emerging Leader Awards provide grant support to early career investigators conducting high-impact, high-risk cancer research. This award is intended to support highly promising projects for which other sources of funding are not readily available or for a separate innovative endeavor that will allow the applicant to pursue a distinct and novel research direction.

Eligibility

  • A PhD, MD or equivalent is required.
  • Applicant must be 3-8 years from the start of an independent faculty research appointment as of December 31, 2019 (i.e., the official start date of the appointment must fall within the calendar years 2011-2016). Exceptions due to prolonged medical or family leave will be considered on a case-by-case basis.
  • Projects appropriate for this award must be centered on evidence-based laboratory, data and medical science.
  • Only one submission per applicant is permitted.
  • This award is not intended to be the main source of funding for the applicant’s laboratory. Applicants must have multi-year independent funding that sustains the central studies of the laboratory (e.g., one or two grants such as NIH/R01, NSF/CAREER, or equivalently substantial multi-year awards). Individual eligibility will be determined during the LOI review stage.
  • Applicants need not be U.S. citizens but must be employed by a U.S. non-profit academic institution.
  •  If selected, finalists must be available to travel to New York City for in-person interviews the week of October 14, 2019.
  • The Mark Foundation for Cancer Research does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.

Award Terms

Submission process

  • Letters of Intent must be submitted online no later than 5 PM Eastern Time on Friday, May 10, 2019. No paper submissions will be accepted. To submit a Letter of Intent, please visit the online portal.
  • Applicants must submit a Letter of Intent that includes:

• Principal Investigator Name, Institution, Project Title
• Project Summary/Abstract (≤ 350 words)
• Principal Investigator’s Biographical Sketch (NIH format)
• Other Support: A list of all current lab grant funding (e.g., NIH/R01, NSF/CAREER Award, or equivalent multi-year awards)
• Key Words: Three to five keywords that are most relevant to the project

  • Letters of Intent may be reviewed in a manner that conceals the applicant’s name and institution.
  • After the Letters of Intent have been evaluated and the review process completed, full applications will be accepted by invitation only. Learn more by reviewing information about the Application Stage.

Key Dates

March 27, 2019…………………….. Letter of Intent Online Portal Opens

May 10, 2019………………………… Letters of Intent Due

Week of June 3……………………… Applications Invited

July 12, 2019…………………………. Applications Due

Week of September 9…………….. Finalists Notified

Week of October 14………………. In-Person Interviews of Finalists

November 1, 2019………………… Selection of Awardees

December 2, 2019………………… Signed Agreements Due

January 1, 2020……………………. Grant Start Date